vendredi 5 octobre 2018

Onco Actu du 5 octobre 2018

2. Etiologie

Is a little radiation good for you? Controversial theory pops up in Senate hearing on EPA transparency plan [Science]

2.11 Etiologie - Alimentation

Processed meat? Really? How to process epidemiological news [The Mermaid's Tale]

2.5 Etiologie - Gènes

Time doesn’t heal all wounds: how DNA damage as we age causes cancer [The Conversation]

3.4.1 Chimioprévention - aspirine

Mass. General-led study supports ability of regular aspirin use to reduce liver cancer risk [Mass. General Hospital]

Low-dose aspirin may lower ovarian cancer risk [Harvard]

Daily Baby Aspirin May Lower Ovarian Cancer Risk [NY Times]

Aspirin and Chemoprevention—Have We Arrived? [JAMA Oncology]

4.12 Biopsies liquides

Guardant Health’s IPO Tops Range, Raising $238M for Cancer Tests [Xconomy]

5.1 Traitements - Pré-clinique

Mayo researchers identify potential new treatment for subset of women with triple-negative breast cancer [Mayo Clinic]

5.10 Traitements - Essais

Study Shows Duvelisib Has Marked Response, Survival Benefit in Difficult-to-Treat Leukemia and Lymphoma Compared with Standard Therapy [ASH]

5.12 Immunothérapies

Analysis Reveals Genomic Effects of a New Cancer Treatment Now in Clinical Trials [Penn Medicine]

5.2.1 Pharma - Partenariats

MD Anderson and Cyclacel Pharmaceuticals announce strategic alliance to study novel Cyclacel medicines in hematological malignancies [MD Anderson Cancer Center]

6.1 Observation

Report Outlines Cancer Risk among Hispanics/Latinos in the United States [ACS]

6.11 Patients

Male doctors said my ‘female’ cancer was incurable. Then a woman took command and gave me hope [STAT]

6.14 Prix Nobel

Thoughts on the Chemistry Nobel Prize [In the Pipeline]

6.3 Associations/Fondations

Precision medicine needs a business mindset in order to flourish [STAT]

6.5 Médecines alternatives/complémentaires

The World Health Organization: Embracing traditional Chinese medicine pseudoscience in ICD-11 [Respectful Insolence]

6.6 Publications

Cancer researcher who once tried to sue critics is up to 40 retracted papers [Retraction Watch]

Mr Smits goes to Washington: Architect of bold European open-access plan hopes to garner US support [Nature]

6.7.1 IA/bioinformatique

Google DeepMind Given Access To Mammograms Of 30,000 Women By Japanese Hospital [Forbes]